BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20237902)

  • 1. The role of Crk/Dock180/Rac1 pathway in the malignant behavior of human ovarian cancer cell SKOV3.
    Wang H; Linghu H; Wang J; Che YL; Xiang TX; Tang WX; Yao ZW
    Tumour Biol; 2010 Jan; 31(1):59-67. PubMed ID: 20237902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of Rac1 by paxillin-Crk-DOCK180 signaling complex is antagonized by Rap1 in migrating NBT-II cells.
    Vallés AM; Beuvin M; Boyer B
    J Biol Chem; 2004 Oct; 279(43):44490-6. PubMed ID: 15308668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elmo1 helps dock180 to regulate Rac1 activity and cell migration of ovarian cancer.
    Wang J; Dai JM; Che YL; Gao YM; Peng HJ; Liu B; Wang H; Linghu H
    Int J Gynecol Cancer; 2014 Jun; 24(5):844-50. PubMed ID: 24819662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of Rac1 by Src-dependent phosphorylation of Dock180(Y1811) mediates PDGFRα-stimulated glioma tumorigenesis in mice and humans.
    Feng H; Hu B; Liu KW; Li Y; Lu X; Cheng T; Yiin JJ; Lu S; Keezer S; Fenton T; Furnari FB; Hamilton RL; Vuori K; Sarkaria JN; Nagane M; Nishikawa R; Cavenee WK; Cheng SY
    J Clin Invest; 2011 Dec; 121(12):4670-84. PubMed ID: 22080864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of adaptor protein Crk in malignant feature of human ovarian cancer cell line MCAS.
    Linghu H; Tsuda M; Makino Y; Sakai M; Watanabe T; Ichihara S; Sawa H; Nagashima K; Mochizuki N; Tanaka S
    Oncogene; 2006 Jun; 25(25):3547-56. PubMed ID: 16491127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Rac1 by RhoG regulates cell migration.
    Katoh H; Hiramoto K; Negishi M
    J Cell Sci; 2006 Jan; 119(Pt 1):56-65. PubMed ID: 16339170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-terminal SH3 domain of CrkII regulates the assembly and function of the DOCK180/ELMO Rac-GEF.
    Akakura S; Kar B; Singh S; Cho L; Tibrewal N; Sanokawa-Akakura R; Reichman C; Ravichandran KS; Birge RB
    J Cell Physiol; 2005 Jul; 204(1):344-51. PubMed ID: 15700267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ankyrin repeat domain 28 (ANKRD28), a novel binding partner of DOCK180, promotes cell migration by regulating focal adhesion formation.
    Tachibana M; Kiyokawa E; Hara S; Iemura S; Natsume T; Manabe T; Matsuda M
    Exp Cell Res; 2009 Mar; 315(5):863-76. PubMed ID: 19118547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ELMO1 and Dock180, a bipartite Rac1 guanine nucleotide exchange factor, promote human glioma cell invasion.
    Jarzynka MJ; Hu B; Hui KM; Bar-Joseph I; Gu W; Hirose T; Haney LB; Ravichandran KS; Nishikawa R; Cheng SY
    Cancer Res; 2007 Aug; 67(15):7203-11. PubMed ID: 17671188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of Rac1 by a Crk SH3-binding protein, DOCK180.
    Kiyokawa E; Hashimoto Y; Kobayashi S; Sugimura H; Kurata T; Matsuda M
    Genes Dev; 1998 Nov; 12(21):3331-6. PubMed ID: 9808620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The bipartite rac1 Guanine nucleotide exchange factor engulfment and cell motility 1/dedicator of cytokinesis 180 (elmo1/dock180) protects endothelial cells from apoptosis in blood vessel development.
    Schäker K; Bartsch S; Patry C; Stoll SJ; Hillebrands JL; Wieland T; Kroll J
    J Biol Chem; 2015 Mar; 290(10):6408-18. PubMed ID: 25586182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of two signaling submodules within the CrkII/ELMO/Dock180 pathway regulating engulfment of apoptotic cells.
    Tosello-Trampont AC; Kinchen JM; Brugnera E; Haney LB; Hengartner MO; Ravichandran KS
    Cell Death Differ; 2007 May; 14(5):963-72. PubMed ID: 17304244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a conserved role for CRKII and Rac in engulfment of apoptotic cells.
    Tosello-Trampont AC; Brugnera E; Ravichandran KS
    J Biol Chem; 2001 Apr; 276(17):13797-802. PubMed ID: 11297528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysyl oxidase regulates actin filament formation through the p130(Cas)/Crk/DOCK180 signaling complex.
    Payne SL; Hendrix MJ; Kirschmann DA
    J Cell Biochem; 2006 Jul; 98(4):827-37. PubMed ID: 16440329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CED-12/ELMO, a novel member of the CrkII/Dock180/Rac pathway, is required for phagocytosis and cell migration.
    Gumienny TL; Brugnera E; Tosello-Trampont AC; Kinchen JM; Haney LB; Nishiwaki K; Walk SF; Nemergut ME; Macara IG; Francis R; Schedl T; Qin Y; Van Aelst L; Hengartner MO; Ravichandran KS
    Cell; 2001 Oct; 107(1):27-41. PubMed ID: 11595183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of CrkII in Fcgamma receptor-mediated phagocytosis.
    Lee WL; Cosio G; Ireton K; Grinstein S
    J Biol Chem; 2007 Apr; 282(15):11135-43. PubMed ID: 17308335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elmo1 inhibits ubiquitylation of Dock180.
    Makino Y; Tsuda M; Ichihara S; Watanabe T; Sakai M; Sawa H; Nagashima K; Hatakeyama S; Tanaka S
    J Cell Sci; 2006 Mar; 119(Pt 5):923-32. PubMed ID: 16495483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The DOCK180/Elmo complex couples ARNO-mediated Arf6 activation to the downstream activation of Rac1.
    Santy LC; Ravichandran KS; Casanova JE
    Curr Biol; 2005 Oct; 15(19):1749-54. PubMed ID: 16213822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major host factors involved in epithelial cell invasion of Campylobacter jejuni: role of fibronectin, integrin beta1, FAK, Tiam-1, and DOCK180 in activating Rho GTPase Rac1.
    Boehm M; Krause-Gruszczynska M; Rohde M; Tegtmeyer N; Takahashi S; Oyarzabal OA; Backert S
    Front Cell Infect Microbiol; 2011; 1():17. PubMed ID: 22919583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1.
    Liu W; Yue F; Zheng M; Merlot A; Bae DH; Huang M; Lane D; Jansson P; Lui GY; Richardson V; Sahni S; Kalinowski D; Kovacevic Z; Richardson DR
    Oncotarget; 2015 Apr; 6(11):8851-74. PubMed ID: 25860930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.